vs
LEXICON PHARMACEUTICALS, INC.（LXRX）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Rocky Mountain Chocolate Factory, Inc.的季度营收约是LEXICON PHARMACEUTICALS, INC.的1.4倍（$7.5M vs $5.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -282.7%，领先280.7%），LEXICON PHARMACEUTICALS, INC.同比增速更快（254.4% vs -4.4%），过去两年LEXICON PHARMACEUTICALS, INC.的营收复合增速更高（124.2% vs 1.9%）
Lexicon制药是一家成立于1995年的生物制药企业，总部位于美国得克萨斯州伍德兰兹，最初名为Lexicon Genetics，专注于开发人类疾病治疗药物。公司凭借专利小鼠基因敲除技术与强大的体内筛选能力，在Genome5000项目中完成了近5000个基因的研究，筛选出大量候选药物靶点。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
LXRX vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.5M | $7.5M |
| 净利润 | $-15.5M | $-155.0K |
| 毛利率 | 96.3% | 34.0% |
| 营业利润率 | -269.1% | 1.1% |
| 净利率 | -282.7% | -2.1% |
| 营收同比 | 254.4% | -4.4% |
| 净利润同比 | 54.0% | 81.7% |
| 每股收益（稀释后） | $-0.04 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $5.5M | $7.5M | ||
| Q3 25 | $14.2M | $6.8M | ||
| Q2 25 | $28.9M | $6.4M | ||
| Q1 25 | $1.3M | $8.9M | ||
| Q4 24 | $1.6M | $7.9M | ||
| Q3 24 | $1.7M | $6.4M | ||
| Q2 24 | $1.6M | $6.4M | ||
| Q1 24 | $1.1M | $7.3M |
| Q4 25 | $-15.5M | $-155.0K | ||
| Q3 25 | $-12.8M | $-662.0K | ||
| Q2 25 | $3.3M | $-324.0K | ||
| Q1 25 | $-25.3M | $-2.9M | ||
| Q4 24 | — | $-847.0K | ||
| Q3 24 | $-64.8M | $-722.0K | ||
| Q2 24 | $-53.4M | $-1.7M | ||
| Q1 24 | $-48.4M | $-1.6M |
| Q4 25 | 96.3% | 34.0% | ||
| Q3 25 | 99.9% | 23.6% | ||
| Q2 25 | 99.9% | 31.1% | ||
| Q1 25 | 97.6% | 10.8% | ||
| Q4 24 | 77.5% | 23.4% | ||
| Q3 24 | 95.9% | 31.8% | ||
| Q2 24 | 89.7% | 12.8% | ||
| Q1 24 | 97.2% | 24.3% |
| Q4 25 | -269.1% | 1.1% | ||
| Q3 25 | -85.9% | -7.0% | ||
| Q2 25 | 12.9% | -2.3% | ||
| Q1 25 | -2034.8% | -30.3% | ||
| Q4 24 | — | -8.9% | ||
| Q3 24 | -3658.4% | -14.3% | ||
| Q2 24 | -3423.3% | -25.4% | ||
| Q1 24 | -4147.6% | -21.7% |
| Q4 25 | -282.7% | -2.1% | ||
| Q3 25 | -90.0% | -9.7% | ||
| Q2 25 | 11.3% | -5.1% | ||
| Q1 25 | -2004.4% | -32.5% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | -3722.6% | -11.3% | ||
| Q2 24 | -3304.2% | -25.9% | ||
| Q1 24 | -4427.9% | -21.9% |
| Q4 25 | $-0.04 | $-0.02 | ||
| Q3 25 | $-0.04 | $-0.09 | ||
| Q2 25 | $0.01 | $-0.04 | ||
| Q1 25 | $-0.07 | $-0.38 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | $-0.18 | $-0.11 | ||
| Q2 24 | $-0.17 | $-0.26 | ||
| Q1 24 | $-0.20 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $96.2M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $107.5M | $6.0M |
| 总资产 | $185.0M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $96.2M | $641.0K | ||
| Q3 25 | $116.0M | $2.0M | ||
| Q2 25 | $139.0M | $893.0K | ||
| Q1 25 | $194.8M | $720.0K | ||
| Q4 24 | $238.0M | $1.1M | ||
| Q3 24 | $258.4M | $973.0K | ||
| Q2 24 | $310.0M | $637.0K | ||
| Q1 24 | $355.6M | $2.1M |
| Q4 25 | $107.5M | $6.0M | ||
| Q3 25 | $120.2M | $6.1M | ||
| Q2 25 | $129.4M | $6.7M | ||
| Q1 25 | $123.0M | $7.0M | ||
| Q4 24 | $145.9M | $9.8M | ||
| Q3 24 | $178.5M | $10.5M | ||
| Q2 24 | $240.0M | $9.0M | ||
| Q1 24 | $288.9M | $10.6M |
| Q4 25 | $185.0M | $20.7M | ||
| Q3 25 | $205.9M | $22.3M | ||
| Q2 25 | $225.6M | $20.1M | ||
| Q1 25 | $297.7M | $21.2M | ||
| Q4 24 | $298.4M | $21.6M | ||
| Q3 24 | $321.1M | $21.1M | ||
| Q2 24 | $373.4M | $19.0M | ||
| Q1 24 | $417.2M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-17.2M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.3M |
| 自由现金流率自由现金流/营收 | — | -16.9% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $-17.2M | $-1.2M | ||
| Q3 25 | $-23.8M | $-488.0K | ||
| Q2 25 | $17.0M | $350.0K | ||
| Q1 25 | $-43.8M | $1.2M | ||
| Q4 24 | $-178.8M | $-2.1M | ||
| Q3 24 | $-53.6M | $-3.5M | ||
| Q2 24 | $-48.5M | $-2.2M | ||
| Q1 24 | $-55.1M | $129.0K |
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | — | $182.0K | ||
| Q1 25 | — | — | ||
| Q4 24 | $-179.8M | — | ||
| Q3 24 | $-53.9M | $-4.6M | ||
| Q2 24 | $-48.8M | $-2.6M | ||
| Q1 24 | — | $-352.3K |
| Q4 25 | — | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | -11600.7% | — | ||
| Q3 24 | -3097.4% | -72.6% | ||
| Q2 24 | -3017.3% | -40.2% | ||
| Q1 24 | — | -4.9% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 17.6% | 17.5% | ||
| Q2 24 | 15.5% | 6.5% | ||
| Q1 24 | 0.0% | 6.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.23× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LXRX
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
